Bruce R.G., Munch L.C., Hoven A.D., Jerauld R.S., Greenburg R., Porter W.H., et al (1997). Urolithiasis associated with the protease inhibitor indinavir. Urol;50(4), 513-518
2.
Gagnon R.F., Tecimer S.N., Watters A.K. and Tsoukas C.M. (2000). Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir. Am J Kidney Dis;36(3), 507-515
Kohan A.D., Armenakas N.A. and Fracchia J.A. (1999). Indinavir urolithiasis: an emerging cause of renal colic in patients with human immunodeficiency virus. J Urol ; 161(6), 1765-1768
5.
Kopp J.B., Miller K.D.Mican J.A., Feuerstein I.M., Vaughan E., Baker C., et al (1997). Crystalluria and urinary tract abnormalities associated with indinavir. Ann Intern Med;127(2), 119-125
6.
Rajs J., Blaxhult A. and Sundelin B. (2000). Sudden unexpected death as a consequence of indinavir-induced nephropathy. A case report. APMIS;108(9), 581-583
7.
Reiter W.J., Schon-Pernerstorfer H., Dorfinger K., Hof-Bauer J. and Marberger M. (1999). Frequency of urolithiasis in individuals seropositive for human immunodeficiency virus treated with indinavir is higher than previously assumed. J Urol;161(4), 1082-1084
8.
Scarletti M., Petter A., Romani N., Lhotta K., Konig P., Maier H., et al (2000). Pyuria in patients treated with indinavir is associated with renal dysfunction. Clin Nephrol;54(4), 261-270
9.
Schwartz B.F., Schenkman N., Armenakas N.A. and Stoller M.L. (1999). Imaging characteristics of indinavir calculi. J Urol;161(4), 1085-1087
